Using stable isotope-labelled tracers in gnotobiotic mice, researchers mapped a previously unknown mechanism by which gut microbiota actively restricts dietary fat absorption. Colonized mice retained up to 12-fold more lipids in gut contents versus germ-free animals. The pathway runs: microbial signals activate host Myd88 → suppress hepatic Cyp7b1 → elevate taurocholate in bile → stimulate phospholipase A1 → degrade phosphatidylcholine → impair micelle formation → reduced luminal lipid uptake. Microbiome diversity correlated inversely with bile phosphatidylcholine levels.
This finding reframes a long-held assumption: the microbiome was known to influence lipid metabolism systemically, but the idea that it enzymatically dismantles the very bile vehicle required for fat absorption is mechanistically novel. Phosphatidylcholine is indispensable for forming mixed micelles that solubilize dietary fats and fat-soluble vitamins; disrupting it upstream could explain inter-individual variation in fat absorption linked to microbiome composition in humans. The Cyp7b1–taurocholate node is a concrete, druggable target—inhibiting phospholipase A1 activity in bile, or modulating Cyp7b1, could potentially treat obesity or fat malabsorption disorders. Caveats are significant: this is entirely mouse data in a highly artificial gnotobiotic context, and the 12-fold effect size may not translate proportionally to humans with established, complex microbiomes. Still, the causal mechanistic chain—traced with isotope labelling and validated with lipidomics and proteomics—elevates this well beyond correlative microbiome research. Paradigm-shifting for the field.
